Y-Intercept (HK)’s OnKure Therapeutics OKUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.5K Buy
+11,288
New +$48.4K ﹤0.01% 1624
2024
Q3
Sell
-5,568
Closed -$84.1K 1895
2024
Q2
$84.1K Buy
+5,568
New +$94.4K ﹤0.01% 1274

Other funds holding OKUR

Y-Intercept (HK)'s OKUR Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 11,288 shares worth $51.5K. The stake represents ﹤0.01% of the portfolio and ranks #1624 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in OKUR as recently as Q2 2024.

Y-Intercept (HK) first reported a position in OKUR in Q2 2024 and has held it in 2 quarters since. The position peaked at $84.1K in Q2 2024. 3 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Y-Intercept (HK) held 11,288 shares of OnKure Therapeutics worth $51.5K as of Q2 2026.
  • OnKure Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1624 holding.
  • Y-Intercept (HK) first reported a position in OnKure Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • Y-Intercept (HK)'s OnKure Therapeutics position peaked at $84.1K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.